Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FB4PH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,231
Award facts
- Contract value 100% obligated
- $16,231.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,231.23 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on November 14, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions such as eczema, asthma, and chronic rhinosinusitis. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order as a child delivery order under a larger contract vehicle.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its extensive pharmaceutical product portfolio across multiple therapeutic domains, positions it as a primary supplier for DoD medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FB4PH?
SPE2DR26FB4PH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FB4PH worth?
The government has obligated $16,231 on SPE2DR26FB4PH.
Is contract SPE2DR26FB4PH an order under another contract?
Yes. SPE2DR26FB4PH is a delivery order under SPE2DR25D2208, an indefinite delivery contract.
Was contract SPE2DR26FB4PH competed?
The extent of competition for SPE2DR26FB4PH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award